CMR Surgical raises $200M to expand Versius robot access across the U.S. (The Robot Report)

CMR Surgical has raised over $200 million in equity and debt to accelerate the global rollout of its Versius Surgical Robotic System, which has already completed more than 30,000 procedures in 30+ countries. The funding round, backed by existing investors and Trinity Capital, underscores growing confidence in CMR’s minimally invasive technology and U.K. life sciences sector. With a compact, modular design and advanced ergonomic features, Versius is gaining traction across multiple specialties and is now the world’s second most-used soft-tissue surgical robot. As CMR eyes U.S. expansion and new clinical trials—including pediatric and transoral surgeries—it’s not just building robots; it’s reshaping the future of surgery, one arm at a time.